by in
Entry Author Date Location
ImmusanT Grabs $12M as Celiac Vaccine Hits Critical Proving Ground 12/22/14 Boston
ImmusanT Receives $12,000,000 Series B Financing 12/22/14 Boston
Xconomy Boston’s Top Stories of Q1 2014: Editor’s Picks 03/31/14 Boston
East Coast Biotech Roundup: ImmusanT, NY Disruptors, Tesaro, & More 03/14/14 Boston
Get a Shot, Have Some Bread: ImmusanT’s Plan For a Celiac Vaccine 03/11/14 Boston
Vertex, Ariad, Alnylam, & More Boston-Area Life Sciences Newsmakers 12/16/11 Boston
Kinvey, Zink, ImmusanT, and More of this Week’s Boston Dealmakers 12/14/11 Boston
ImmusanT, Developing Celiac Disease Treatments, Closes $20M Series A 12/13/11 Boston
ImmusanT Secures $20,000,000 Series A Round 12/13/11 Boston
Page 1 of 1